Literature DB >> 3536945

Improved grading of bone tumors with the monoclonal antibody Ki-67.

E Vollmer, A Roessner, J Gerdes, W Mellin, H Stein, S Chong-Schachel, E Grundmann.   

Abstract

A total of 60 bone tumors and tumor-like lesions presenting various grades of malignancy were investigated immunohistologically with the monoclonal antibody Ki-67 directed against a cell proliferation-associated nuclear antigen. The results obtained agree well with those of flow cytometric and autoradiographic studies on similar tumor entities. The monoclonal antibody Ki-67 was found to be a handy and reliable tool for improved grading of bone tumors.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3536945     DOI： 10.1007/BF00395924

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  3 in total

1.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

2.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

3.  Biological characterization of human bone tumors. VII. Detection of malignancy in a giant cell tumor of bone by flow cytometric DNA-analysis.

Authors:  W Mellin; A Roessner; E Grundmann; B Wörmann; W Hiddemann; M Immenkamp
Journal:  Pathol Res Pract       Date:  1985-12       Impact factor: 3.250
  3 in total
  7 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Biological characterization of human bone tumors. X. The proliferation behavior of macrophages as compared to fibroblastic cells in malignant fibrous histiocytoma and giant cell tumor of bone.

Authors:  A Roessner; J Vassallo; E Vollmer; G Zwadlo; C Sorg; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

4.  A comparative study of cell proliferation markers in breast carcinomas.

Authors:  A S Leong; S Vinyuvat; C Suthipintawong; J Milios
Journal:  Clin Mol Pathol       Date:  1995-04

5.  A new quantitative test method for cell proliferation based on detection of the Ki-67 protein.

Authors:  C L Klein; M Wagner; C J Kirkpatrick; T G Van Kooten
Journal:  J Mater Sci Mater Med       Date:  2000-02       Impact factor: 3.896

6.  Immunohistochemical detection of proliferating cells in colorectal carcinomas and adenomas with the monoclonal antibody Ki-67. Preliminary data.

Authors:  C Hoang; M Polivka; P Valleur; P Hautefeuille; J Nemeth; A Galian
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.

Authors:  Flemming Brandt Sorensen; Kenneth Jensen; Michael Vaeth; Henrik Hager; Anette Mariane Daa Funder; Akmal Safwat; Johnny Keller; Mariann Christensen
Journal:  Sarcoma       Date:  2009-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.